The State of Clinical Trials 2012
Most clinical trials currently do not meet their deadlines and approximately 85% experience delays; 95% of these must contend with delays of more than a month. As a result, the drug development business model has been modified considerably to include clinical data management outsourcing solutions to help overcome these delays.
In addition, Pharmaceutical, Biotechnology, and Medical Device organizations are increasingly seeking unique expertise and capabilities when selecting sourcing partners -- ones with functional services like data management, coding, biostatistics and statistical programming, and laboratory facilities, logistics and translation services all gaining significant importance.
Post-marketing studies have also seen an increase in recent years, owing to the importance given by the medical community to the long-term safety aspects of drugs. Technical know-how, capacities, compliance and the ability to complete clinical trials within the stipulated time are the primary factors that companies examine before making a decision.
At DZS Clinical Services, we realize that selecting the right strategic outsourcing partner is important. We are very familiar with the rigorous supplier-selection process used by many of our CRO, Pharmaceutical and Biotech and Medical Device clients, especially when they are evaluating suppliers in technology markets.
DZS Clinical Services is designed specifically keeping in mind the growing challenges of pharmaceutical companies in the year 2012 in the areas of research and development and trial management. Our services focus on outsourcing of high-end niche transactional processes, such as SAS consulting and statistical programming, clinical data management, medical coding, study set-up, clinical trial project management and CDISC/SDTM/ADaM data conversion.